Unity Biotechnology, Inc. Operating Lease, Payments
Unity Biotechnology, Inc. reported Operating Lease, Payments of $1.28 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2025-04-22
- Unity Biotechnology, Inc. operating lease, payments for the quarter ending 2025-03-31 was $1.28M, a 3.23% increase year-over-year.
- Unity Biotechnology, Inc. operating lease, payments for the quarter ending 2024-03-31 was $1.24M, a 3.17% increase year-over-year.
- Unity Biotechnology, Inc. operating lease, payments for the quarter ending 2023-12-31 was $1.21M, a 3.15% increase year-over-year.
- Unity Biotechnology, Inc. operating lease, payments for the quarter ending 2023-09-30 was $1.20M, a 29.12% decline year-over-year.
- Unity Biotechnology, Inc. operating lease, payments for fiscal 2024 was $4.96M, a 3.20% increase from fiscal 2023.
- Unity Biotechnology, Inc. operating lease, payments for fiscal 2023 was $4.81M, a 23.44% decline from fiscal 2022.
- Unity Biotechnology, Inc. operating lease, payments for fiscal 2022 was $6.28M, a 5.56% decline from fiscal 2021.
- Unity Biotechnology, Inc. operating lease, payments for fiscal 2021 was $6.65M, a 14.77% increase from fiscal 2020.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-03-31 | $1.28M 10-Q · filed 2025-04-22 | |||
| 2024-12-31 | $4.96M 10-K · filed 2025-03-07 | |||
| 2024-03-31 | $1.24M 10-Q · filed 2025-04-22 | $2.45M derived: sum of 2 quarters · filed 2025-04-22 | $3.65M derived: sum of 3 quarters · filed 2025-04-22 | $4.85M derived: sum of 4 quarters · filed 2025-04-22 |
| 2023-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.41M derived: sum of 2 quarters · filed 2025-03-07 | $3.61M derived: sum of 3 quarters · filed 2025-03-07 | $4.81M 10-K · filed 2025-03-07 |
| 2023-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.40M derived: sum of 2 quarters · filed 2023-11-13 | $3.60M 10-Q · filed 2023-11-13 | $4.77M derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.40M 10-Q · filed 2023-08-08 | $3.57M derived: sum of 3 quarters · filed 2025-03-07 | $5.27M derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-03-31 | $1.20M 10-Q · filed 2023-05-09 | $2.37M derived: sum of 2 quarters · filed 2025-03-07 | $4.07M derived: sum of 3 quarters · filed 2025-03-07 | $5.78M derived: sum of 4 quarters · filed 2025-03-07 |
| 2022-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.87M derived: sum of 2 quarters · filed 2025-03-07 | $4.58M derived: sum of 3 quarters · filed 2025-03-07 | $6.28M 10-K · filed 2025-03-07 |
| 2022-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.40M derived: sum of 2 quarters · filed 2023-11-13 | $5.11M 10-Q · filed 2023-11-13 | $6.78M derived: sum of 4 quarters · filed 2024-04-15 |
| 2022-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.42M 10-Q · filed 2023-08-08 | $5.09M derived: sum of 3 quarters · filed 2024-04-15 | $6.76M derived: sum of 4 quarters · filed 2024-04-15 |
| 2022-03-31 | $1.70M 10-Q · filed 2023-05-09 | $3.38M derived: sum of 2 quarters · filed 2024-04-15 | $5.04M derived: sum of 3 quarters · filed 2024-04-15 | $6.71M derived: sum of 4 quarters · filed 2024-04-15 |
| 2021-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | $3.34M derived: sum of 2 quarters · filed 2024-04-15 | $5.00M derived: sum of 3 quarters · filed 2024-04-15 | $6.65M 10-K · filed 2024-04-15 |
| 2021-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $3.33M derived: sum of 2 quarters · filed 2022-11-08 | $4.98M 10-Q · filed 2022-11-08 | $6.60M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $3.31M 10-Q · filed 2022-08-12 | $4.94M derived: sum of 3 quarters · filed 2023-03-15 | $6.55M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | $1.65M 10-Q · filed 2022-05-10 | $3.28M derived: sum of 2 quarters · filed 2023-03-15 | $4.89M derived: sum of 3 quarters · filed 2023-03-15 | $6.61M derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $3.24M derived: sum of 2 quarters · filed 2023-03-15 | $4.96M derived: sum of 3 quarters · filed 2023-03-15 | $5.80M 10-K · filed 2023-03-15 |
| 2020-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $3.33M derived: sum of 2 quarters · filed 2021-11-10 | $4.17M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $2.56M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $839.00K 10-Q · filed 2021-05-11 |